AgomAb Therapeutics NV American Depositary Shares AGMB
$8.65
-22.07%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $37.50
- Implied Upside
- +333.5%
- Price Target Range
- $28.00 – $60.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-25 | Piper SandlerYasmeen Rahimi |
Initiates coverage on | Overweight | $60 |
| 2026-08-19 | Cantor FitzgeraldYanni Souroutzidis |
Initiates coverage on | Overweight | — |
| 2026-07-23 | B. Riley SecuritiesWilliam Woods |
Initiates coverage on | Buy | $34 |
| 2026-06-22 | HC Wainwright & Co.Patrick R. Trucchio |
Initiates coverage on | Buy | $35 |
| 2026-03-03 | Leerink PartnersThomas Smith |
Initiates coverage on | Outperform | $36 |
| 2026-03-03 | JP MorganAnupam Rama |
Initiates coverage on | Overweight | $32 |
| 2026-03-03 | Morgan StanleyJudah Frommer |
Initiates coverage on | Overweight | $28 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $8.65
- Market Cap
- $425.99 million
- 52-Week Range
- $8.56 – $17.82
- Average Volume
- 177K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.